Terms: = Ovarian cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE
91 results:
1. The Clinicopathological Significance of the Cyclin D1/E1-Cyclin-Dependent Kinase (CDK2/4/6)-Retinoblastoma (RB1/pRB1) Pathway in Epithelial ovarian cancers.
Lashen A; Algethami M; Alqahtani S; Shoqafi A; Sheha A; Jeyapalan JN; Mongan NP; Rakha EA; Madhusudan S
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612869
[TBL] [Abstract] [Full Text] [Related]
2. Identification of prognostic factors and construction of nomogram to predict cancer-specific survival for patients with ovarian granulosa cell tumors.
Zhang Y; Zhang Z; Ding X; Zhang K; Dai Y; Cheng W; Luo C
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2046. PubMed ID: 38507268
[TBL] [Abstract] [Full Text] [Related]
3. Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers.
Payton M; Belmontes B; Hanestad K; Moriguchi J; Chen K; McCarter JD; Chung G; Ninniri MS; Sun J; Manoukian R; Chambers S; Ho SM; Kurzeja RJM; Edson KZ; Dahal UP; Wu T; Wannberg S; Beltran PJ; Canon J; Boghossian AS; Rees MG; Ronan MM; Roth JA; Minocherhomji S; Bourbeau MP; Allen JR; Coxon A; Tamayo NA; Hughes PE
Nat Cancer; 2024 Jan; 5(1):66-84. PubMed ID: 38151625
[TBL] [Abstract] [Full Text] [Related]
4. Multifactor assessment of ovarian cancer reveals immunologically interpretable molecular subtypes with distinct prognoses.
Guo Y; Li S; Li C; Wang L; Ning W
Front Immunol; 2023; 14():1326018. PubMed ID: 38143770
[TBL] [Abstract] [Full Text] [Related]
5. Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis.
Collins KE; Wang X; Klymenko Y; Davis NB; Martinez MC; Zhang C; So K; Buechlein A; Rusch DB; Creighton CJ; Hawkins SM
Front Endocrinol (Lausanne); 2023; 14():1162786. PubMed ID: 37621654
[TBL] [Abstract] [Full Text] [Related]
6. OTUD7B deubiquitinates and stabilizes YAP1 to upregulate NUAK2 expression, thus accelerating gastric cancer procession.
Guo Z; Guo L
Dig Liver Dis; 2024 Feb; 56(2):352-362. PubMed ID: 37429790
[TBL] [Abstract] [Full Text] [Related]
7. Serum expression of tumor marker CA242 in patients with different gynecological diseases.
Zhu J; Li H
Lab Med; 2023 Nov; 54(6):613-617. PubMed ID: 37035887
[TBL] [Abstract] [Full Text] [Related]
8. Beta-Caryophyllene Enhances the Anti-Tumor Activity of Cisplatin in Lung cancer Cell Lines through Regulating Cell Cycle and Apoptosis Signaling Molecules.
Ahmed EA; Abu Zahra H; Ammar RB; Mohamed ME; Ibrahim HM
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500446
[TBL] [Abstract] [Full Text] [Related]
9. Sensitive electrochemical detection of polymorphisms in IL6 and TGFβ1 genes from ovarian cancer DNA patients using EcoRI and DNA hairpin-modified gold electrodes.
Meftah M; Habel A; Baachaoui S; Yaacoubi-Loueslati B; Raouafi N
Mikrochim Acta; 2022 Dec; 190(1):15. PubMed ID: 36479645
[TBL] [Abstract] [Full Text] [Related]
10. A review on the role of PCGEM1 lncRNA in cancer.
Ghafouri-Fard S; Khoshbakht T; Hussen BM; Baniahmad A; Taheri M; Mokhtari M
Pathol Res Pract; 2022 Dec; 240():154223. PubMed ID: 36403313
[TBL] [Abstract] [Full Text] [Related]
11. One-stop molecular classification of endometrial carcinoma using comprehensive next-generation sequencing.
Li Y; Chen R; Yuan M; Wang D; Fu C; Chen R; Lei C; Zhou Q
Int J Cancer; 2022 Dec; 151(11):1969-1977. PubMed ID: 36036365
[TBL] [Abstract] [Full Text] [Related]
12. Genomic and TCR profiling data reveal the distinct molecular traits in epithelial ovarian cancer histotypes.
Zhu S; Zhang C; Cao D; Bai J; Yu S; Chen J; Wang J; Ren T; Yang J; Yu M; Xiao X; Gong Y; Guan Y; Li P; Yue Y; Yin R; Wang Y; An R; Lou G; Yuan J; Zhang G; Xia X; Yang L; Xiang Y
Oncogene; 2022 May; 41(22):3093-3103. PubMed ID: 35468938
[TBL] [Abstract] [Full Text] [Related]
13. Overexpression of miR-138-5p Sensitizes Taxol-Resistant Epithelial ovarian cancer Cells through Targeting Cyclin-Dependent Kinase 6.
Liang M; Li Q; Shi S; Tian YN; Feng Y; Yang Y; Dong M; Zhang J; He J
Gynecol Obstet Invest; 2021; 86(6):533-541. PubMed ID: 34818258
[TBL] [Abstract] [Full Text] [Related]
14. lncRNA SNHG15 Promotes ovarian cancer Progression through Regulated cdk6 via Sponging miR-370-3p.
Wang Y; Ding M; Yuan X; Jiao R; Zhu D; Huang W; Deng W; Liu Y
Biomed Res Int; 2021; 2021():9394563. PubMed ID: 34734088
[TBL] [Abstract] [Full Text] [Related]
15. miR-486 Promotes the Invasion and Cell Cycle Progression of ovarian cancer Cells by Targeting CADM1.
Li C; Wang Y; Wang H; Wang B; Wang Y; Li N; Qin Y; Wang Y
Anal Cell Pathol (Amst); 2021; 2021():7407086. PubMed ID: 34395181
[TBL] [Abstract] [Full Text] [Related]
16. Genetic variants of CHEK1, PRIM2 and cdk6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival.
Mu R; Liu H; Luo S; Patz EF; Glass C; Su L; Du M; Christiani DC; Jin L; Wei Q
Int J Cancer; 2021 Sep; 149(6):1302-1312. PubMed ID: 34058013
[TBL] [Abstract] [Full Text] [Related]
17. Exosomal miR-21-5p contributes to ovarian cancer progression by regulating cdk6.
Cao J; Zhang Y; Mu J; Yang D; Gu X; Zhang J
Hum Cell; 2021 Jul; 34(4):1185-1196. PubMed ID: 33813728
[TBL] [Abstract] [Full Text] [Related]
18. LINC00324 facilitates cell proliferation through competing for miR‑214‑5p in immature ovarian teratocarcinoma.
Chen M; Zhang M; Xie L; Wu S; Zhong Y
Int J Mol Med; 2021 Jan; 47(1):397-407. PubMed ID: 33416104
[TBL] [Abstract] [Full Text] [Related]
19. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway.
Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H
Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213
[TBL] [Abstract] [Full Text] [Related]
20. ΜiR-182-5p functions as a tumor suppressor to sensitize human ovarian cancer cells to cisplatin through direct targeting the cyclin dependent kinase 6 (cdk6).
Duan L; Yan Y; Wang G; Xing YL; Sun J; Wang LL
J BUON; 2020; 25(5):2279-2286. PubMed ID: 33277846
[TBL] [Abstract] [Full Text] [Related]
[Next]